ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Undetected Lesion as a Risk Factor for Recurrence in Patients Transplanted for HCC, The

L. Teperman, E. Cahan, A. David, B. Gelb, G. Morgan, H. Tobias

NYU SOM, New York, NY
U of M, Ann Arbor, MI

Meeting: 2013 American Transplant Congress

Abstract number: A703

Background: OLT is the definitive treatment for HCC. Vascular invasion, tumor size, and proliferation are known risk factors for recurrence post-OLT. Undetected lesions <1cm are considered incidental findings, and not risk factors. This study reviews possible risk factors related to recurrence and mortality. Methods: A retrospective evaluation of 164 patients undergoing OLT for HCC from '07-'12 was performed. T1/T2-weighted MRIs within 90 days of OLT were compared to explants.Lesion size, number and degree of invasion were reviewed. Post-OLT CT/MRI studies were screened for HCC. Groups with/without undetected lesions found on pathology were compared for risk factors. Results: Prospective MRI interpretation with/without contrast (gadolinium/Eovist) revealed 223 HCCs in 164 patients, 1.40 per patient. Pathology demonstrated 518 lesions (3.16 per patient). MRI sensitivity for any lesion was 44%, 229/518. Sensitivity for lesion detection <1cm was only 7.53%, 11/146. Severity was understated prior to explant, with 31.1%, 51/164 demonstrating microvascular invasion vs. 2.4%, 4/164 with macrovascular invasion. Recurrent HCC was 20.7%, 34/164 patients. 16 biopsy proven, and 18 diagnosed by imaging. Median recurrence interval was 16 mos. 25 patients expired after OLT; many of them from recurrent HCC. In this subset, 66.4%, 71/107 lesions were undetected pre-OLT MRI. 60%, 15/25 deceased patients had vascular invasion, 2 macrovascular. 53%, 8/15 with microvascular invasion developed metastatic HCC. MRI failed to detect 1.75 lesions/patient in this subgroup. Discussion: MRI underestimates the number and overall tumor burden. Data demonstrates that 44% of lesions were identified on pre-OLT MRI (7.53% of lesions <1cm). A comparison was made in patients with/without undetected lesions to determine risk factors for invasion, recurrence and mortality. The mortality secondary to recurrence post-OLT is significant in HCC patients with microvascular invasion. Rates of invasion, recurrence and mortality with/without undetected lesions are 47.5%, 25.0% and 23.8% vs. 28.4%, 20.9% and 10.4% respectively. Conclusion: Pre-OLT MRI has poor sensitivity in defining lesions <1cm. Incidence of microvascular invasion is higher, 47.5% vs. 28.4%, when undetected lesions are found. Invasion is a known cause for recurrence. Presence of lesions <1cm demonstrates higher recurrences rates 25.0% vs. 20.9% and appears to be clinically important. A more than twofold increased mortality rate 23.8% vs. 10.4% was seen.

Teperman, L.: Grant/Research Support, Onyx/Bayer.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Teperman L, Cahan E, David A, Gelb B, Morgan G, Tobias H. Undetected Lesion as a Risk Factor for Recurrence in Patients Transplanted for HCC, The [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/undetected-lesion-as-a-risk-factor-for-recurrence-in-patients-transplanted-for-hcc-the/. Accessed May 17, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences